MONDAY, March 23, 2026 — A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher...

The U.S. Food and Drug Administration announced on...

Novo Nordisk's FDA nod for higher-dose Wegovy could boost healthcare ETFs' appeal, offering diversified exposure to the obesity drug market.

THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it...

THURSDAY, April 2, 2026 — A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it...

CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the High Dose Regimen of Spinraza (nusinersen),...

BIIB gains after the FDA clears higher-dose Spinraza, with data showing improved motor function and potential to counter rising SMA competition.

THURSDAY, March 26, 2026 — The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug...

TUESDAY, March 24, 2026 -- The U.S. Food and Drug Administration has approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist,...

THURSDAY, April 2, 2026 — Milk sold at convenience stores in four states is being recalled amid concerns about possible plastic...